Impressum

Campus Berlin-Buch GmbH
Robert-Rössle-Straße 10
D-13125 Berlin

Fax: 030-94 89 38 12
E-Mail: info@campusberlinbuch.de

Managing Directors:
Dr. Christina Quensel, Dr. Ulrich Scheller

Court of Registry: Charlottenburg (Berlin) District Court
Commercial Register Number: HRB 57456

Editorial responsibility: Responsible according to German law: Christine Minkewitz (address as listed above)

Disclaimer of liability: The information of this website was compiled with utmost care. Despite meticulous checks, we assume no liability for the content of external links. The operators of the linked websites are solely responsible for their content.

Sponsors
This website is supported by:
Akademie der Gesundheit Berlin/Brandenburg e.V.
Charité - Universitätsmedizin Berlin
Eckert & Ziegler AG
Erste Wohnungsgenossenschaft Berlin-Pankow eG
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)
Ludwig Hoffmann Quartier
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Vattenfall Wärme Berlin AG

Further sponsors are:
Autohaus Golbeck

Photos:
Thomas Oberländer, Peter Himsel, Ralf Grömminger, Jürgen Dachner, Schütte, Matthies, Lösch, Hugel, MDC, Berlin-Buch Management GmbH - Regionalmanagement, David Ausserhofer, Christine Minkewitz, EPO GmbH, HOWOGE, Campus Berlin-Buch GmbH, Akademie der Gesundheits Berlin-Brandenburg e.V.

Imagefilm:
MYP Media

News Buch Berlin

Berlin honors outstanding deep-tech companies—including MyoPax

This year, for the first time, a Deep Tech Award was presented in the Bio & Health Tech category. The winner is MyoPax, a spin-off of the Max Delbrück Center and Charité.

more ...

Eckert & Ziegler Receives “Best Managed Companies Award” Once Again

Eckert & Ziegler SE (ISIN DE0005659700) has won the “Best Managed Companies Award” for the third time in a row. With this honor, Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federati...

more ...

Eckert & Ziegler with a Successful Start to the Year. 2026 Forecast Confirmed.

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) increased its sales in the first quarter of 2026 by 7% to €72.9 million compared with the same period last year.

more ...